Alnylam Pharmaceuticals, Inc.

Report date
12/31/2025
Quarter
2025 Q4
Filed
2/9/2026
Shares
42,476
Value ($000)
16,874
Weight
0.2%
2024 Q1 - 2025 Q4 (6 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).